Alex Roepers on two deep-value special situations: $DCH and $NOMD

Episode Summary

Executive Summary: Andrew Walker and Alex Ropers discuss two deep-value, catalyst-driven stocks: Dauch (DCH), a leveraged auto supplier merger story with sizeable synergy potential and governance concerns, and Nomad Foods (NOMD), a European frozen-food platform facing temporary operational pressure but supported by insider buying, dividends, and takeover optionality. Both are framed as cheap, improving businesses with possible double-upside over 18-24 months.

Main Topics: Dauch (DCH) merger thesis and valuation (Priority: 5/5): The hosts argue that the merged American Axle/Doualy business is undervalued relative to its EBITDA, with synergy realization and improved industry conditions creating a path to rerating. Corporate governance and 'dark arts' signaling (Priority: 5/5): They debate CEO pay, the company being named after the CEO's family, low insider ownership, and large PSU awards as signals of management confidence versus empire-building risk. Synergy underwriting and leverage in auto parts (Priority: 5/5): A detailed discussion of the $300M synergy target, how it breaks down across SG&A, procurement, and operations, and whether the company's leverage is manageable as cash flow ramps. Nomad Foods turnaround and competitive pressure (Priority: 5/5): Nomad is presented as a branded frozen-food leader with stable demand, but also facing private-label competition, underinvestment, and a new CEO reset. Capital allocation, dividends, and buybacks (Priority: 4/5): Both companies are evaluated through the lens of debt reduction, dividend policy, and the potential for share repurchases once leverage targets are met. European exposure and valuation discounts (Priority: 3/5): They discuss whether European listed or Europe-heavy businesses deserve lower multiples, concluding that the exposure is more opportunity than risk in these cases.

Key Arguments: Dauch is cheap enough that the market does not need heroic assumptions; if synergies land and the auto cycle holds, the stock could double or triple. The synergy target appears credible because it is broken into identifiable buckets: SG&A cuts, purchasing savings, and plant/footprint optimization. Management incentives on Dauch may be more aligned than critics think because the CEO's PSU package only vests if the stock rises materially. Governance is still a real risk at Dauch: naming the company after the CEO and paying high compensation could signal empire-building if performance stalls. Nomad is a quality branded frozen-food business with recurring demand, sustainability appeal, and strong shelf-positioned brands. Nomad's recent problems are framed as repairable: new leadership, more marketing and R&D, and insider buying suggest a turnaround is underway. The 7% dividend at Nomad is not viewed as a threat to solvency; the company can still delever while paying it. Both names could be attractive targets for activists or strategic buyers if execution improves and valuation remains depressed. European exposure is not viewed as a fatal flaw; in both cases it is seen as a global, diversified setup rather than a pure regional bet.

Data Points: Dauch share price: $6.32 - Opening valuation reference for DCH on the NYSE Dauch market cap: about $5 billion / later described as a $6 stock with leverage - Used to frame the company's size and cheapness Dauch combined sales: about $11 billion - Post-merger revenue base for the combined business Dauch LTM EBITDA: about $1.5 billion - Used to discuss leverage and valuation Dauch net debt: over $5 billion - Rough leverage discussion after merger Dauch synergy target: $300 million+ EBITDA - Management's expected merger synergies Dauch synergy run-rate by end of 2026: $100 million - Near-term milestone discussed as likely confirmation point Dauch current synergy capture: about $35 million - Mentioned as already achieved early in integration Dauch leverage target: below 2.5x net debt/EBITDA - Management's stated threshold before capital returns Dauch CEO PSU vesting threshold: $12 to $22 per share by end of 2029 - Long-term equity incentive package described as 'dark arts' signaling Nomad share price: $10.21 - Current trading level at time of discussion Nomad prior peak: $30 in 2021 - Context for the stock's collapse and valuation reset Nomad sales: about $3.5 billion - Approximate annual revenue base Nomad EPS forecast: about $1.50 - Forward earnings estimate used in valuation framing Nomad dividend yield: over 7% - Income component emphasized as part of the wait-and-see return Nomad valuation multiples: about 5.5x earnings and under 7x EBITDA - Used to argue the stock is inexpensive Nomad dividend amount: 17 cents per quarter - Described as sustainable and not forcing balance-sheet stress Nomad annual dividend cash cost: about $90 million - Discussion of dividend versus debt paydown Nomad market share/asset utilization: plants at 20-40% utilization in some cases - CEO commentary indicating underused capacity and room for improvement

Pivotal Quotes: "cheap does not always equal alpha" — Andrew Walker: Introductory caution about value investing and the two names discussed "This company can earn $1.50, $2... you're looking at a double or triple on the stock in the next year and a half to two years" — Alex Ropers: Bull case for Dauch based on synergies and rerating potential "I think you're getting paid to wait, paid to see it work out" — Alex Ropers: Core thesis on Nomad Foods despite operational issues and margin pressure

Implications: The episode frames both stocks as classic catalyst value ideas: cheap, imperfect, and potentially rewarding if management executes. Listeners should focus on synergy delivery, leverage reduction, insider alignment, and whether temporary operating issues are truly fixable.